I. Russo, S. Cazzolla, F. Pampaloni, and M. Alaibac, “Omalizumab for the treatment of chronic spontaneous urticaria: association between body mass index and outcome”, Dermatol Pract Concept, vol. 12, no. 4, p. e2022148, Oct. 2022, doi: 10.5826/dpc.1204a148.